| Title: |
A retrospective study of patients treated with by oral anticancer drugs: Impact of pharmacy consultation |
| Authors: |
Clou, Emmanuelle; Dubois, Antonin; Gaudas, Julien; Palisson, Hugo; Chetouane, Kahina; Talarmin, Chloé; Meynial, Olivia; Nguyen, Jacqueline; Assoun, Sandra; Benderra, Marc-Antoine; Nasrallah, Dhekra; Esteso, Adoraction; Avenin, Danièle; Galula, Gilles; Ghebriou, Djamel; Gligorov, Joseph; Khalil, Ahmed; Korenbaum, Clément; Prebet, Coralie; Foka-Tichoue, Hervé; Lotz, Jean-Pierre; Debrix, Isabelle |
| Source: |
European Journal of Oncology Pharmacy ; volume 5, issue 4, page e00033 ; ISSN 2032-7072 |
| Publisher Information: |
Ovid Technologies (Wolters Kluwer Health) |
| Publication Year: |
2022 |
| Description: |
Introduction: Pharmacists can contribute to improve prevention and management of patients treated with oral anticancer drugs. The aim of this study was to describe pharmacist interventions in drug-related problems (DRPs), medication optimization, and patient management. Methods: The pharmaceutical process allows obtaining exhaustive list of usual patient treatment, patient education, and telephonic follow-up at home. During pharmacy consultation and telephonic follow-up, the number and type of pharmacist interventions were collected and classified into 3 categories: DRPs, medication optimization, and patient management. During telephonic follow-up, pharmacists detected adverse events. Results: From February 2016 to May 2020, 224 pharmacy consultations were conducted. A total of 508 pharmacist interventions (248 for pharmacy consultation and 260 for telephonic follow-up) were conducted, with an average of 2.3 pharmacist interventions per patient. Pharmacist interventions were 44.4% for patient management, 29.6% for DRPs, and 26.0% for medication optimization. After pharmacy consultation, 36.2% of patients' usual treatments were amended. Two hundred thirteen adverse events (AEs) were reported, and 38.8% of patients had one or more AEs. AEs detected were 15 for temporary discontinuation of oral anticancer drugs, 25 for emergency consultations, and 3 for hospitalizations. Conclusion: Pharmacy consultation has shown that pharmacists can contribute to optimize medicinal care for patients with cancer. |
| Document Type: |
article in journal/newspaper |
| Language: |
English |
| DOI: |
10.1097/op9.0000000000000033 |
| DOI: |
10.1097/OP9.0000000000000033 |
| Availability: |
https://doi.org/10.1097/op9.0000000000000033; https://journals.lww.com/10.1097/OP9.0000000000000033 |
| Rights: |
http://creativecommons.org/licenses/by-nc-nd/4.0/ |
| Accession Number: |
edsbas.9E8D0F71 |
| Database: |
BASE |